MR diffusion and perfusion
Can they replace PET? By Marco Essig MD, Professor of Radiology at the German Cancer Research Centre, outlines relevant presentations at the ECR.
PET/CT
MR contrast agents: A step up from compartmental to targeted imaging
Andrea Martini and Joerg Larsen, of the Institute for Roentgendiagnostics, Braunschweig Teaching Hospitals, Germany, discuss nanotechnology, hybrid imaging and the quest for a personalised medicine.
A novel PET tracer for early detection of Alzheimers
Amyloidb (Ab) plaque formation is a hallmark of Alzheimers disease (AD) and precedes the onset of dementia. Australian researchers reported the first data on the validity in humans of a new PET tracer binding to Ab. Their data suggest that 18F-BAY94-9172 of Bayer Schering Pharma AG can reliably detect Ab deposition and thereby aid early diagnosis, differential diagnosis, and therapeutic…
PET-CT for radiation therapy planning:
For individualised radiotherapy, high-precision delineation and characterisation of the tumour is critical. If highest radiation doses are delivered in a targeted fashion, the chance of tumour cell kill increases and tumour control probability is enhanced.
The new IMPAX Solution Suite
Agfa Healthcare's new IMPAX solution suites offer PACS and RIS to cover hospital data handling and cardiovascular, cardiology, orthopaedics, mammography and radiology data.
4-D imaging and Bio-System-Radiology
The Virtual Physiological Human By Hans-Ulrich Kauczor MD PhD, Director and Chairman of Radiology at Heidleburg University Clinic, and radiologists Frederik Giesel MD MBA and Hendrik von Tengg-Kobligk MD of the German Cancer Research Centre in Heidleburg, Germany.
PET/CT and children
PET/CT imaging exhibits significantly higher sensitivity, specificity and accuracy than conventional imaging when it comes to detecting malignant tumours in children, according to research published in the Journal of Nuclear Medicine (12/07).
Diagnostic accuracy of PET and CT in early stage lung cancer
A multi-institutional study recently compared whether positron emission tomography (PET) or computed tomography (CT) performs more efficient in the characterization of solitary lung nodules (SPNs). Previously performed studies were either limited by small sample sizes or carried out more than a decade ago with outdated technology and methods.
Quantitative PET imaging
Visual analysis of PET scans for non-Hodgkin lymphoma may be improved by using standardised uptake value in monitoring response to treatment, according to research published in the Journal of Nuclear Medicine.
Optical molecular imaging
Carestream's molecular imaging group focuses on life sciences, developing high-performance digital imaging systems, imaging agents, film and accessories for the research and drug discovery/development markets.
Demand for PET/CT systems soars
Dr Thomas Beyer: `PET/CT is a non-invasive imaging modality that captures anatomical and metabolic data in a single scan´
Euro 900 million for molecular imaging R&D
The Technology initiative “Molecular Imaging” aims to strengthen the synergies of science and industry in research and development of new technologies in order to significantly improve diagnostic and treatment options, for example for cardiovascular diseases, cancer or Alzheimer's.
Symposium: Innovations in medical imaging
The Forum Medizintechnik-Pharma - an association that provides a recognised contribution to the development of the co-operative environment in medicine, technology and pharmaceuticals, met for a symposium in Germany this July.
World's first human brain images scanned with a PET/MRI hybrid system
The next-generation of hybrid imaging technology was presented at this years SNM meeting in Washington, D.C: The first human brain images from a prototype PET/MRI system, which is developed by a collaborative team of German and US researchers from the Universities of Tübingen and Tennessee, as well as Siemens Medical Solutions.
Diagnosis of Cardiac Diseases
For decades, non-invasive cardiac assessment has been at the center of interest. Non-invasive imaging modalities, such as MSCT, MRI, SPECT, PET, and echocardiography, provide valuable cardiac information, and all have been used to measure cardiac morphology, function, perfusion, viability of myocardium, and coronary anatomy for clinical management and research. The last decade brought major…
It will identify millions with 'silent heart disease'
'If you want to find a needle in a haystack, X-ray is a good tool. Now imagine how much easer that would be if the needle could glow.'
Peter Loescher: The unknown famous manager
When the Siemens board of directors announced its decision for the new Siemens CEO on Sunday, the economic world was surprised: Not only that the name Peter Löscher was never mentioned in the previous discussions about a successor of Klaus Kleinfeld, but hardly anybody knew Loescher´s name in any enconomic context.
Expanding medical horizons
This was the motto of the ECR 2007 in Vienna, where a group of high-ranking experts discussed diseases of the 21st century; research competition between the US and Europe; the conditions needed to progress leading medical R&D - moderated by Congress President Professor Christian J Herold.
Molecular imaging
GE was the first to undertake molecular imaging development on a large scale. 'You have to be a very special company to work in this discipline,' Reinaldo Garcia, President and Chief Executive Officer of GE Healthcare International, pointed out, when we asked for an update on his company's progress in this field
2007 Congress will welcome radiologists to Vienna
The European Congress of Radiology (ECR) is a never-ending story of surprises, excitement, and success. Year after year, more scientists, radiologists eager to learn, and partners from industrial companies flock to this excellent meeting.
Surviving the financial climate
Earlier disease detection will save healthcare services
The 8th International Conference On Nuclear Cardiology
The ICNC meeting attracs a lot of attention since there is a focus on PET and CT.
PET/CT
PET/CT combines PET's ability to precisely measure regional myocardial blood flow with the capability of multislice CT imaging.
What's new in PET technology?
Positron emission tomography (PET) is a fancy tool for metabolic imaging. This week Tom Lewellen from the University of Washington Medical Center in Seattle takes a detailed look on what is to expect of the recent developments in PET detector technology.
Innovations:
By Professor Maximilian F Reiser, director of the Institute of Clinical Radiology at the University Clinic, Munich, Germany
